Prognosis: Breakthrough

What We Know About Immunity

Prognosis: Breakthrough

In the race to study immunity to the virus, scientists first focused on antibodies -- proteins that stick to and disable foreign invaders. That’s because creating antibodies is the basis for most successful vaccines, so scientists are interested in learning who develops coronavirus antibodies, how long they stick around, and how effective they are at keeping people from getting infected again. But recent studies show there may be another weapon inside the human body that can rouse fresh antibody soldiers long after the first have left the battlefield. Bloomberg senior editor Jason Gale explains that T cells may be part of the key to blunting the coronavirus contagion. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Next Episodes

Prognosis: Breakthrough

The Data Disaster in the U.S. @ Prognosis: Breakthrough

πŸ“† 2020-07-29 22:02 / βŒ› 00:14:43


Prognosis: Breakthrough

Why a Vaccine Won't Create Instant Immunity @ Prognosis: Breakthrough

πŸ“† 2020-07-27 22:23 / βŒ› 00:15:06


Prognosis: Breakthrough

Why The Crisis Hurts Maine's Lobster Industry @ Prognosis: Breakthrough

πŸ“† 2020-07-24 23:31 / βŒ› 00:12:57


Prognosis: Breakthrough

The Campaign to Lure You Back to the Doctor @ Prognosis: Breakthrough

πŸ“† 2020-07-22 23:42 / βŒ› 00:17:45


Prognosis: Breakthrough

The Latin American Country That's Beating Covid @ Prognosis: Breakthrough

πŸ“† 2020-07-20 22:25 / βŒ› 00:14:01